logo

For the Inventor, By the Inventor

Athens, NY, United States of America

William Bert Geiss

This inventor holds 15 USPTO granted patents and 4 published patent applications, primarily in Pharmaceutical Chemistry. Top assignees: Activbiotics, Inc., Merck Sharp + Dohme Corp., Activbiotics Pharma, LLC. Active years: 2002-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Bert Geiss. Retrieved from https://idiyas.com/inventor/william-bert-geiss

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15 

% Patents Active = 26.7

Average Co-Inventor Count = 6.3

ph-index = 4

Forward Citations = 34(Granted Patents)


Location History:

  • Albany, NY (US) (2005 - 2016)
  • Athens, NY (US) (2002 - 2020)

Company Filing History:

goldMedal4 out of 6 
 
Activbiotics, Inc.
 patents
silverMedal3 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
bronzeMedal2 out of 4 
 
Activbiotics Pharma, LLC
 patents
4. 2 out of 12 
 
Cardax Pharmaceuticals, Inc.
 patents
5. 1 out of 97 
 
Albany Molecular Research, Inc.
 patents
6. 1 out of 1,535 
 
Astrazeneca Ab
 patents
7. 1 out of 37 
 
Bone Care International, Inc.
 patents
8. 1 out of 3,556 
 
University of Michigan
 patents

Years Active: 2002-2020

Loading Chart...
Areas of Expertise:
Omacetaxine
Cephalotaxine
Cyclopropyl Compounds
Polycyclic Guanine
Benzodiazepine
Rifamycin
Carotenoids
Astaxanthin
Sulfhydryl Rifamycins
Reflux Disease
Vitamin D2
15 patents (USPTO):Explore Patents
1. 10597401 - Methods and intermediates for the preparation of omacetaxine and cephalotaxine derivatives thereof (2020-03-24),
2. 9422266 - Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment (2016-08-23),
3. 8957062 - Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment (2015-02-17),
4. 8349858 - Polycyclic guanine derivatives and use thereof (2013-01-08),
5. 7759338 - Soluble 1,4 benzodiazepine compounds and stable salts thereof (2010-07-20),
6. 7547692 - Rifamycin analogs and uses thereof (2009-06-16),
7. 7494991 - Rifamycin analogs and uses thereof (2009-02-24),
8. 7435861 - Methods for synthesis of carotenoids, including analogs, derivatives, and synthetic and biological intermediates (2008-10-14),
9. 7342011 - Rifamycin analogs and uses thereof (2008-03-11),
10. 7271165 - Rifamycin analogs and uses thereof (2007-09-18),
11. 7247752 - Methods for the synthesis of astaxanthin (2007-07-24),
12. 7220738 - Rifamycin analogs and uses thereof (2007-05-22),
13. 7078399 - Sulfhydryl rifamycins and uses thereof (2006-07-18),
14. 6919379 - Compounds useful in reflux disease (2005-07-19),
15. 6359012 - Method for making 24(S)-hydroxyvitamin D2 (2002-03-19),

Sure, I can help with that. Here is the article about inventor William Bert Geiss:

Title: The Innovator Profile: William Bert Geiss

Introduction: William Bert Geiss, a prolific inventor based in Athens, NY, has made significant contributions in the field of pharmaceuticals with a total of 15 patents to his name.

Latest Patents: Geiss's latest patents include groundbreaking innovations such as methods and intermediates for the preparation of omacetaxine and cephalotaxine derivatives, which offer potential in the treatment of proliferative and infectious diseases. Additionally, his work on substituted cyclopropyl compounds has shown promise in treating type 2 diabetes and related conditions by targeting the G-protein coupled receptor GPR-119.

Career Highlights: Throughout his career, Geiss has been associated with renowned companies in the pharmaceutical industry, including Activbiotics, Inc. and Merck Sharp & Dohme Corporation. His aptitude for innovation and dedication to advancing healthcare solutions have been instrumental in shaping the industry.

Collaborations: William Bert Geiss has collaborated with esteemed professionals such as Arthur F. Michaelis and John Henry Van Duzer. Together, they have worked on pioneering research projects that have paved the way for novel pharmaceutical developments.

Conclusion: In conclusion, William Bert Geiss stands out as a visionary inventor whose patents and contributions have had a profound impact on the pharmaceutical landscape. His innovative spirit and collaborative efforts continue to inspire advancements in the field, promising a brighter future for healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…